Literature DB >> 33441627

Molecular basis of the interaction of the human tyrosine phosphatase PTPN3 with the hepatitis B virus core protein.

Mariano Genera1,2, Barbara Quioc-Salomon3,4,5, Antonin Nourisson1, Baptiste Colcombet-Cazenave1,2, Ahmed Haouz6, Ariel Mechaly6, Mariette Matondo7, Magalie Duchateau7, Alexander König8, Marc P Windisch8, Christine Neuveut3,4,9, Nicolas Wolff1, Célia Caillet-Saguy10.   

Abstract

Interactions between the hepatitis B virus core protein (HBc) and host cell proteins are poorly understood, although they may be essential for the propagation of the virus and its pathogenicity. HBc has a C-terminal PDZ (PSD-95, Dlg1, ZO-1)-binding motif (PBM) that is responsible for interactions with host PDZ domain-containing proteins. In this work, we focused on the human protein tyrosine phosphatase non-receptor type 3 (PTPN3) and its interaction with HBc. We solved the crystal structure of the PDZ domain of PTPN3 in complex with the PBM of HBc, revealing a network of interactions specific to class I PDZ domains despite the presence of a C-terminal cysteine in this atypical PBM. We further showed that PTPN3 binds the HBc protein within capsids or as a homodimer. We demonstrate that overexpression of PTPN3 significantly affects HBV infection in HepG2 NTCP cells. Finally, we performed proteomics studies on both sides by pull-down assays and screening of a human PDZ domain library. We identified a pool of human PBM-containing proteins that might interact with PTPN3 in cells and that could be in competition with the HBc PBM during infection, and we also identified potential cellular partners of HBc through PDZ-PBM interactions. This study opens up many avenues of future investigations into the pathophysiology of HBV.

Entities:  

Year:  2021        PMID: 33441627      PMCID: PMC7806630          DOI: 10.1038/s41598-020-79580-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  75 in total

1.  The arginine-rich carboxy-terminal domain of the hepatitis B virus core protein mediates attachment of nucleocapsids to cell-surface-expressed heparan sulfate.

Authors:  Peter Vanlandschoot; Freya Van Houtte; Benedikte Serruys; Geert Leroux-Roels
Journal:  J Gen Virol       Date:  2005-01       Impact factor: 3.891

2.  Phosphoacceptors threonine 162 and serines 170 and 178 within the carboxyl-terminal RRRS/T motif of the hepatitis B virus core protein make multiple contributions to hepatitis B virus replication.

Authors:  Jaesung Jung; Seong Gyu Hwang; Yong-Joon Chwae; Sun Park; Ho-Joon Shin; Kyongmin Kim
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

Review 3.  Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses.

Authors:  Ronald T Javier; Andrew P Rice
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

4.  Molecular Basis of the Interaction of the Human Protein Tyrosine Phosphatase Non-receptor Type 4 (PTPN4) with the Mitogen-activated Protein Kinase p38γ.

Authors:  Pierre Maisonneuve; Célia Caillet-Saguy; Marie-Christine Vaney; Edoo Bibi-Zainab; Kristi Sawyer; Bertrand Raynal; Ahmed Haouz; Muriel Delepierre; Monique Lafon; Florence Cordier; Nicolas Wolff
Journal:  J Biol Chem       Date:  2016-05-31       Impact factor: 5.157

Review 5.  Intracellular transport and egress of hepatitis B virus.

Authors:  Marie-Lise Blondot; Volker Bruss; Michael Kann
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

6.  Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs.

Authors:  Simon Rousseau; Nick Morrice; Mark Peggie; David G Campbell; Matthias Gaestel; Philip Cohen
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

7.  The CCPN data model for NMR spectroscopy: development of a software pipeline.

Authors:  Wim F Vranken; Wayne Boucher; Tim J Stevens; Rasmus H Fogh; Anne Pajon; Miguel Llinas; Eldon L Ulrich; John L Markley; John Ionides; Ernest D Laue
Journal:  Proteins       Date:  2005-06-01

8.  A kinase chaperones hepatitis B virus capsid assembly and captures capsid dynamics in vitro.

Authors:  Chao Chen; Joseph Che-Yen Wang; Adam Zlotnick
Journal:  PLoS Pathog       Date:  2011-11-17       Impact factor: 6.823

9.  Quantifying domain-ligand affinities and specificities by high-throughput holdup assay.

Authors:  Renaud Vincentelli; Katja Luck; Juline Poirson; Jolanta Polanowska; Julie Abdat; Marilyne Blémont; Jeremy Turchetto; François Iv; Kevin Ricquier; Marie-Laure Straub; Anne Forster; Patricia Cassonnet; Jean-Paul Borg; Yves Jacob; Murielle Masson; Yves Nominé; Jérôme Reboul; Nicolas Wolff; Sebastian Charbonnier; Gilles Travé
Journal:  Nat Methods       Date:  2015-06-08       Impact factor: 28.547

Review 10.  Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?

Authors:  Claire D James; Sally Roberts
Journal:  Pathogens       Date:  2016-01-18
View more
  2 in total

1.  Host PDZ-containing proteins targeted by SARS-CoV-2.

Authors:  Célia Caillet-Saguy; Fabien Durbesson; Veronica V Rezelj; Gergö Gogl; Quang Dinh Tran; Jean-Claude Twizere; Marco Vignuzzi; Renaud Vincentelli; Nicolas Wolff
Journal:  FEBS J       Date:  2021-05-01       Impact factor: 5.622

2.  Quantitative fragmentomics allow affinity mapping of interactomes.

Authors:  Gergo Gogl; Boglarka Zambo; Camille Kostmann; Alexandra Cousido-Siah; Bastien Morlet; Fabien Durbesson; Luc Negroni; Pascal Eberling; Pau Jané; Yves Nominé; Andras Zeke; Søren Østergaard; Élodie Monsellier; Renaud Vincentelli; Gilles Travé
Journal:  Nat Commun       Date:  2022-09-17       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.